NEWS: FDA Finally Rejected Qnexa

November 6th, 2010 by Jamie

NEWS: FDA Finally Rejected Qnexa Recently, we have posted here that Qnexa may pose safety risks based on the initial screenings of FDA. However, months after the results of the ...

NEWS: FDA Finally Rejected Qnexa

Recently, we have posted here that Qnexa may pose safety risks based on the initial screenings of FDA. However, months after the results of the initial screening were posted, the federal health regulators have yet again posted an update to the public regarding Qnexa.

Qnexa is manufactured by Vivus Inc, and has been touted by many as a promising weight loss drug for more than a decade. According to Vivus Inc., the Food and Drug Administration has rejected the drug. FDA did not approve the release of the new drug and asked for more study results along with additional information regarding the possible health risks associated with it.

The Food and Drug Administration did not require new clinical studies but more may be needed if Vivus Inc., won’t be able to provide the information that the agency requires. Vivus Inc., plans to respond to FDA in six weeks.

FDA is very much aware of the increasing rates of obesity in the United States and an effective weight loss drug may be needed to help this rate to go down; however, it is very important to look for a drug that can provide safe weight loss benefits without causing health threatening side effects.